Administering Lupron over Zoladex Conditionally Permissible by Carriers

Why This Topic Matters

Coverage policies can affect reimbursement, patient billing, and drug selection workflow in urology practices. Understanding the general policy context helps billing staff recognize when documentation, beneficiary notice, and payer-specific requirements may affect claim handling.

Article Sections

1. Carrier may allow billing patient more for Lupron when justified

   Discusses a draft carrier policy affecting reimbursement and beneficiary payment for LHRH drug therapy in prostate cancer care. The section also references related payer considerations and practice-level billing impact.

2. Coding and reporting considerations

   Summarizes the general billing codes referenced for the injectable therapies and notes quantity reporting concepts for different dosing intervals. The section also mentions a modifier used when beneficiary billing is applicable.